Dura mater enhancement on 3T MRI is associated with cortical lesion burden in multiple sclerosis

Robert Zivadinov1,2, Mehak Semy3, Alexander Bartnik3

  • 1Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 77 Goodell Street, Suite 450, Buffalo, NY, 14203, USA. rz4@buffalo.edu.

Journal of Neurology
|April 6, 2026
PubMed
Abstract

Insights

Dura mater enhancement (DME) on MRI in people with multiple sclerosis (pwMS) is linked to a higher burden of cortical lesions. This finding helps clarify the relationship between meningeal changes and brain pathology in MS.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimmunology

Background:

  • Post-contrast FLAIR MRI shows meningeal signal enhancement in people with multiple sclerosis (pwMS).
  • The biological specificity and relationship of these enhancement patterns to cortical lesion pathology are uncertain.

Purpose of the Study:

  • To evaluate the association between cortical lesion burden and distinct patterns of meningeal enhancement (ME) on MRI in pwMS.
  • Specific patterns investigated include dura mater enhancement (DME), leptomeningeal enhancement (LME), and meningeal perivascular enhancement (MPVE).

Main Methods:

  • 214 pwMS underwent 3T MRI, including 3D FLAIR pre- and post-contrast imaging.
  • Meningeal enhancement (ME) and MPVE were visually classified; cortical lesions were quantified using a validated multi-modal approach.
  • Analyses were adjusted for covariates and corrected for multiple comparisons.

Main Results:

  • DME was observed in 45.3% of pwMS, and was significantly associated with a higher number and volume of cortical lesions.
  • DME frequency correlated strongly with cortical lesion number (r=0.59) and volume (r=0.56).
  • DME independently predicted cortical lesion number and volume, explaining 12-15% of variance.

Conclusions:

  • Dura mater enhancement (DME) on 3T MRI is associated with increased cortical lesion burden in people with multiple sclerosis.
  • This association provides further insight into the pathological mechanisms underlying MS.